Building compliant hardware is an important step to bringing a connected medical device to market. But equally important is developing a compliant software platform. What most teams don’t realize is that their prototype app, clinical trial app, and commercial app don’t necessarily require separate builds, rewrites, and regulatory validation. In fact, rebuilding at every stage of product development results in delays, costs, and compliance gaps.
This article breaks down the true cost of building software from scratch versus adopting a regulatory-ready MedTech platform designed to support every stage—from MVP through clinical trials, regulatory submission, and commercial launch—on a single foundation. If your company is racing to market with a connected device, understanding this difference could save you millions, shave months off your timeline, and dramatically reduce your regulatory risk.
Scenario 1: Building Your Own Platform from Scratch
Many biosensor and connected-device companies choose to build their software entirely from the ground up, often believing it provides greater control or flexibility.
In practice, this usually means rebuilding the same foundational software capabilities that nearly every physiological monitoring product ultimately requires, while simultaneously navigating regulatory expectations around software lifecycle, risk management, and data integrity.
By contrast, leveraging a regulatory-ready MedTech platform developed under an ISO 13485-certified QMS, with software lifecycle considerations (IEC 62304), risk management (ISO 14971), HIPAA- and CFR Part II readiness can significantly reduce development time, cost, and execution risk.
To illustrate the reality, let’s consider just the patient-facing mobile app of a connected device application.
If you are a connected-device company, your patient app will need to include:
1. Secure user access & identity
- Account creation and authentication
- Session management
- Credential recovery
- Role awareness (patient vs support/admin)
This is foundational and non-negotiable
2. Device connection & status awareness
- Device pairing and re-pairing workflows
- Connection state handling
- Battery and device health indicators
- Last-sync and data freshness visibility
Without this, patient trust and adherence drop quickly.
3. Physiological data visibility
- Near-real-time data display
- Historical trends (day / week / month)
- Consistent time-series visualization
- Baseline and change-over-time framing
This is the primary driver of patient engagement.
4. Context capture & annotation
- Events such as meals, activity, symptoms, or medications
- Timestamped inputs
- Overlay of context on physiological data
Without context, physiological data loses meaning.
5. Engagement mechanics (non-clinical)
- Informational notifications
- Wear / sync / charge reminders
- Status-driven nudges
- Passive reinforcement loops
These features support engagement without asserting clinical claims.
6. Reliability & data integrity
- Offline handling and recovery
- Background syncing
- Graceful error handling
- Data consistency safeguards
Patients expect their data to be there, every time.
7. Privacy, security & trust
- Encrypted data in transit and at rest
- Consent handling
- Access controls
- Auditability
Trust is part of the user experience.
What This Means in Practice
Every one of these capabilities:
- Takes time to design
- Requires careful engineering
- Introduces edge cases
- Must be tested, maintained, and evolved
- Eventually intersects with regulatory expectations
And most importantly, none of them are differentiators for your device. This means that you have just spent countless hours, manpower, and capital on an aspect of your product that is necessary, but won’t actually do anything to make it stand out in the market.
Scenario 2: Using a Regulatory-Ready MedTech Platform
For companies that want to avoid the cost, risk, and complexity of building from scratch, the alternative is adopting a regulatory-ready MedTech platform designed specifically for connected medical devices. This is where the NEX Platform by Sequenex stands apart.
Rather than stitching together multiple vendors, rebuilding apps for each development phase, and creating regulatory documentation from the ground up, teams can rely on a single, unified foundation built for speed, compliance, and scalability. NEX offers the advantages of a regulatory-ready MedTech platform while still allowing companies to customize their user experience and device-specific workflows.
Rapid Development With a Prebuilt Software Foundation
Mobile, Cloud, and Dashboard Infrastructure Ready on Day One
NEX provides out-of-the-box architecture for iOS, Android, cloud services, analytics dashboards, and admin portals. Teams can immediately begin configuring their application rather than spending months defining and building core infrastructure.
Configurable UI and Feature Set
Instead of coding every screen, workflow, and data flow from scratch, product teams can tailor existing components to match their device’s needs. This avoids large engineering lifts and reduces verification and validation requirements.
Built-In BLE Integration for Connected Devices
NEX was designed for biosensors, CGMs, and other wireless medical instruments, so BLE support is already built in. Teams gain:
- Pre-integrated BLE communication workflows
- Reliable reconnection, data packet handling, and security
- Cross-platform consistency across iOS and Android
This dramatically reduces the most common source of launch delays and integration bugs.
Compliance and Documentation Ready for Regulatory Submission
Because NEX is developed under an ISO 13485:2016-certified QMS, much of the regulatory structure is already in place. Companies can leverage:
- Prevalidated architecture
- Established design control practices
- Embedded traceability and documentation pathways
- Reduced regulatory burden during audits and submissions
With a regulatory-ready MedTech platform, teams eliminate the need to recreate verification, validation, and compliance mechanisms from scratch.
Accelerated Time to Market
With core features, infrastructure, and compliance already built, companies typically reach clinical-ready or commercial-ready software in a few months. This speed is critical in competitive markets like CGM, biosensors, and RPM solutions, where product timelines often determine market share.
Significant Cost Reduction
Because the foundation is already built and validated, companies avoid:
- Extensive custom development
- Architecture rebuilds
- BLE reintegration
- Multi-phase app rewrites
- Large engineering teams
NEX replaces unpredictable seven-figure development cycles with a far more cost-effective model focused on configuration and device-specific customization.
Scalability Without Rewrites
NEX’s unified architecture supports:
- Postmarket surveillance
- Updates and patches
- New devices and product lines
- New markets and regulatory regions
- Updated workflows and features
- Growth from small pilots to commercial scale
Comparison Table
Aspect | Build from Scratch | Use NEX Platform |
Development Time | 12–18+ months | A few months |
Development Cost | $500k–$3M+ | Significantly reduced |
Regulatory Compliance | Create everything from scratch | ISO 13485 QMS-aligned, compliance-ready |
Customization | Full control, high engineering lift | Prebuilt and configurable |
Complexity | High (BLE, mobile, cloud) | Low (integrations included) |
Scalability | Requires continuous investment | Built-in scalability |
Risk | High (bugs, delays, audits) | Lower (prevalidated foundation) |
What’s Included in the Sequenex NEX Platform
The NEX regulatory-ready MedTech platform already includes a pre-built, configurable patient-facing software foundation, consisting of:
- Mobile app architecture (iOS & Android)
- Configurable onboarding and authentication flows
- Proven device connectivity patterns
- Reusable data visualization components
- Event and context modeling
- Secure data handling and access controls
- Background sync and resilience patterns
- Configurable, non-clinical engagement logic
These capabilities have been designed, implemented, and exercised as part of a reusable platform developed under a controlled quality system.
Of course, final validation, regulatory claims, and intended use always remain the responsibility of the device sponsor, but with NEX, the foundational software does not start from zero.
Final Takeaway: NEX is the Fastest Path to a Regulatory-Ready Connected Device
Choosing the right software foundation can determine whether a connected medical device reaches market on time, stays compliant, and scales successfully. While building from scratch can introduce unnecessary costs, risks, and delays, NEX offers a streamlined alternative: a single, regulatory-ready MedTech platform that supports every stage from MVP through clinical trials, regulatory submissions, and commercial launch.
If your team is evaluating the smartest path forward for your connected device, we’d love to show you how NEX, our regulatory-ready MedTech platform, can accelerate development, reduce complexity, and eliminate costly rewrites.Connect with us to learn how NEX can support your entire MedTech lifecycle.
